Clinical Trial Update: Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the effects of cannabidiol and tetrahydrocannabinol on the microbiome and neuroinflammation in people with HIV. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Cannabidiol (cannabidiol)
• Tetrahydrocannabinol (delta-9-tetrahydrocannabinol)

Snippet

Sponsor: University of California, San Diego | Conditions: HIV, Cannabis | Phase 2 | Status: RECRUITING